Aura Share Price

Aura Share Price

NASDAQ: AURA | Small Cap | Healthcare
$6.99
-$0.14 (-2.03%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Aura Stock Performance

Open
$7.11
Prev. Close
$7.13
Circuit Range
N/A
Day Range
$6.83 - $7.17
Year Range
$4.82 - $9.53
Volume
34,001
Average Traded
$6.97

Aura Share Price Today

As of 20 November 2026, Aura Biosciences, Inc.'s share price is $6.99. The stock opened at $7.11, compared to its previous close of $7.13. During today's trading session, Aura Biosciences, Inc.'s share price traded between $6.83 and $7.17, with an average price of $7.00. Over the past 52 weeks, the stock has recorded a high of $9.53 and a low of $4.82. In terms of performance, Aura Biosciences, Inc.'s share price has declined by 6.43% over the last six months and is up 5.91% on a year-on-year basis.

Aura Share Price Chart

Line chart of the Aura price trend over the selected period. The price fell overall, ranging from 7.01 to 7.20, ending at 7.13.
$6.83$7.17
L
Show Current Price
H

Aura Stock Fundamentals & Key Indicators

Market Cap
$421.76M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-47.65%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-25.47%

Aura Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.56-$33.69-$45.64-$32.07
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.81%-35.47%29.73%

Aura Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$58.76-$76.41-$86.92-$106.19
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-30.04%-13.75%-22.17%

Aura Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets19.6921.8823.2827.23
Current Assets149.74160.62231.79196.7
Total Assets169.43182.5255.08223.94
Non Current Liabilities14.1315.6216.8717.9
Current Liabilities18.3814.9112.3610.46
Total Liabilities32.5230.5329.2328.35
Shareholders' Equity136.91151.97225.85195.58

Aura Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-84.74-79.81-63.85-54.6
Investing35.668.82-113.96-67.87
Financing77.161.697.2995.63

About Aura

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Aura Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.07
$7.00
+13.74%
Oct 2026
$6.23
$6.15
-2.46%
Sep 2026
$7.18
$6.30
-18.01%
Aug 2026
$7.04
$7.69
+9.54%
Jul 2026
$7.13
$7.02
-1.13%
Jun 2026
$7.46
$7.10
-4.95%
May 2026
$6.93
$7.47
+5.81%
Apr 2026
$6.88
$7.06
+5.53%
Mar 2026
$5.87
$6.69
+13.39%
Feb 2026
$5.86
$5.90
+4.98%
Jan 2026
$5.52
$5.62
+3.02%
Dec 2025
$6.20
$5.46
-17.35%

Aura Share Price FAQs